SCHEMBL569011

SCHEMBL569011

O=CN1CCCCCNC1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.35
CA2 P00918 1/20 0.32
CHKA P35790 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11316788 0.90
Pyrrolidine SCHEMBL28239962 0.85 ALDH1A1 (0.47) ALDH1A1HSD17B10CA2CHKAKDM4E
SCHEMBL224305 0.82
SCHEMBL519409 0.78 ALDH1A1 (0.38) ALDH1A1HSD17B10CA2CHKAKDM4E
SCHEMBL518594 0.74 CXCR4 (0.37) ALDH1A1HSD17B10CA2CHKAKDM4E
SCHEMBL20055722 0.73 HSD17B10 (0.52) ALDH1A1HSD17B10CA2KDM4E
SCHEMBL2638 0.73
SCHEMBL518261 0.73 HSD17B10 (0.52) ALDH1A1HSD17B10CA2KDM4E
SCHEMBL463775 0.73 HSD17B10 (0.52) ALDH1A1HSD17B10CA2KDM4E
SCHEMBL1521924 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601192-A1 FUSED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2013-06-12 EP disclosed
WO-2012018909-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-02-09 WO disclosed
EP-2323978-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-05-25 EP disclosed
WO-2010018874-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed
EP-1761539-A1 INDOLE DERIVATIVE AND USE FOR TREATMENT OF CANCER Takeda Pharmaceutical Company Limited (JP) 2007-03-14 EP disclosed
WO-2005118587-A1 INDOLE DERIVATIVE AND USE FOR TREATMENT OF CANCER TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-12-15 WO disclosed